Method of decreasing the bitterness of a pharmaceutical dosage form containing zopiclone
US8889686B2 · kind B2 · utility
0Cited by
9References
1Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 1, 2013 |
| Grant date | Nov 18, 2014 |
| Priority date | — |
| Expiry date | Jul 1, 2033 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C59/245
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
L malate salts of (6-(5-chloro-2-pyridyl)-5-[(4-methyl-1-piperazinyl)carbonyloxy]-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazine) are disclosed for decreasing the bitterness of eszopiclone dosage forms
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.